Methyl 2-Oxoindoline-6-carboxylate - CAS 14192-26-8
Catalog: |
BB009273 |
Product Name: |
Methyl 2-Oxoindoline-6-carboxylate |
CAS: |
14192-26-8 |
Synonyms: |
Methyl Oxindole-6-carboxylate; 2-Oxo-6-indolinecarboxylic Acid Methyl Ester; 6-(Methoxycarbonyl)-2-indolone; 1H-Indole-6-carboxylic acid, 2,3-dihydro-2-oxo-, methyl ester; 6-Indolinecarboxylic acid, 2-oxo-, methyl ester; 2-Oxo-2,3-Dihydro-1H-indole-6-carboxylic acid methyl ester; Methyl 2-oxoindoline-6-carboxylate |
IUPAC Name: | methyl 2-oxo-1,3-dihydroindole-6-carboxylate |
Description: | An impurity of Nintedanib. Nintedanib is a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor, and platelet-derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. |
Molecular Weight: | 191.18 |
Molecular Formula: | C10H9NO3 |
Canonical SMILES: | COC(=O)C1=CC2=C(CC(=O)N2)C=C1 |
InChI: | InChI=1S/C10H9NO3/c1-14-10(13)7-3-2-6-5-9(12)11-8(6)4-7/h2-4H,5H2,1H3,(H,11,12) |
InChI Key: | YFTGUNWFFVDLNM-UHFFFAOYSA-N |
Boiling Point: | 388.1±42.0°C at 760 mmHg |
Melting Point: | 209-211°C |
Purity: | ≥95% |
Density: | 1.283±0.06 g/cm3 |
Solubility: | Soluble in Chloroform (Slightly), Methanol (Slightly) |
Appearance: | White to Off-white Solid |
Storage: | Store at -20°C |
MDL: | MFCD03095196 |
LogP: | 1.10580 |
GHS Hazard Statement: | H302 (97.56%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P272, P280, P301+P312, P302+P352, P321, P330, P333+P313, P363, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021130731-A1 | Substituted tricyclic compounds | 20191227 |
WO-2020256721-A1 | Antib0dy-alk5 inhibitor conjugates and their uses | 20190619 |
WO-2020256751-A1 | Antib0dy-alk5 inhibitor conjugates and their uses | 20190619 |
CN-111662223-A | Process for producing indolinone derivative and intermediate thereof | 20190308 |
WO-2020013803-A1 | Antibody-alk5 inhibitor conjugates and their uses | 20180709 |
Complexity: | 264 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 191.058243149 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 191.058243149 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 55.4 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.6 |
-
Catalog: BB009173
(+/-)-trans-Oxirane-2,3-dicarboxylic acid
Detail
-
Catalog: BB021353
(+)-O,O'-Di-p-toluoyl-D-tartaric Acid
Detail
-
Catalog: BB010056
(±)-cis-Cyclopentane-1,2-dicarboxylic acid
Detail
-
Catalog: BB012630
(+)-Dibenzoyl-D-tartaric Acid
Detail
-
Catalog: BB015442
(±)-8a-Methyl-3,4,8,8a-tetrahydro-1,6(2H,7H)-naphthalenedione
Detail
-
Catalog: BB028257
(±)-2-Acetoxypropionic acid
Detail
-
Catalog: BB036558
(+)-O,O'-Dibenzoyl-D-tartaric Acid Monohydrate
Detail
-
Catalog: BB027076
(±)-Diethyl trans-4-cyclohexene-1,2-dicarboxylate
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS